ArriVent BioPharma Inc. C... (AVBP)
undefined
undefined%
At close: undefined
26.72
0.49%
After-hours Dec 13, 2024, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21
Net Income -69.33M -36.91M -51.61M
Depreciation & Amortization - - -
Stock-Based Compensation 895.00K 424.00K 66.67K
Other Working Capital 11.22M -9.95M -4.23M
Other Non-Cash Items - -2.38M 42.67M
Deferred Income Tax - - -
Change in Working Capital 12.60M -7.15M -3.94M
Operating Cash Flow -55.84M -43.63M -12.59M
Capital Expenditures - - -
Acquisitions - - -
Purchase of Investments -25.00M - -
Sales Maturities Of Investments 25.00M - -
Other Investing Acitivies - - -40.00M
Investing Cash Flow - - -40.00M
Debt Repayment - - -
Common Stock Repurchased - - -
Dividend Paid - - -
Other Financial Acitivies 42.86M 169.72M 119.82M
Financial Cash Flow 42.86M 169.72M 89.87M
Net Cash Flow -12.98M 126.09M 37.28M
Free Cash Flow -55.84M -43.63M -12.59M